Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...] …
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...] …
West Virginia provider groups are applauding a newly passed law to bar drugmaker 340B contract pharmacy restrictions in the state [...] …
Two weeks after the Mississippi House passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy [...] …
Less than four days remain for stakeholders to comment on the highly anticipated bipartisan senate draft 340B program overhaul, and [...] …
Significant gaps in hospital and health system’s financial data, including 340B program use, “limit transparency for policymakers, researchers, and consumers,” [...] …
West Virginia Gov. Jim Justice (R) signed into law today a bill to prohibit drugmaker 340B contract pharmacy restrictions, making [...] …
The Kansas state house and senate have passed separate budget bills with late added amendments to prohibit drugmaker 340B contract [...] …
After a federal appeals court upheld Arkansas’ 340B contract pharmacy access law, a major drug manufacturer has asked a federal [...] …